Many patients find compounded options more accessible when insurance won't cover branded medications
View the current Trimi GLP-1 offer (official Trimi page) What Buyers Who Skipped the Verification Checklist Found Out Later Quick Answer: The documented failure modes in the compounded GLP-1 category include dosing errors with multidose vials, cold-chain failures during shipping, and counterfeit products where the pharmacy named on the label didn't compound - or sometimes didn't even exist
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound) are FDA-approved for type 2 diabetes and obesity management
CagriSema FDA approval timeline Novo Nordisk submitted the New Drug Application (NDA) to the FDA on December 18, 2025 , for chronic weight management in adults with obesity or overweight with a weight-related comorbidity